BioStem Technologies, Inc.
BSEM · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $10 | $49 | $73 | $103 |
| % Growth | -78.8% | -32% | -29.5% | – |
| Cost of Goods Sold | $1 | $1 | $1 | $4 |
| Gross Profit | $9 | $49 | $72 | $99 |
| % Margin | 87.9% | 98.6% | 98.8% | 96.5% |
| R&D Expenses | $2 | $2 | $2 | $1 |
| G&A Expenses | $0 | $7 | $7 | $8 |
| SG&A Expenses | $6 | $46 | $65 | $90 |
| Sales & Mktg Exp. | $0 | $40 | $58 | $81 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $48 | $66 | $91 |
| Operating Income | $1 | $0 | $5 | $8 |
| % Margin | 13.8% | 0.2% | 7.2% | 8.2% |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | $1 | $0 | $5 | $8 |
| Tax Expense | $1 | $1 | $1 | -$7 |
| Net Income | $1 | -$1 | $4 | $16 |
| % Margin | 7.3% | -1.1% | 6.2% | 15.1% |
| EPS | 0.045 | -0.034 | 0.27 | 0.94 |
| % Growth | 234.3% | -112.5% | -71.3% | – |
| EPS Diluted | 0.03 | -0.034 | 0.17 | 0.68 |
| Weighted Avg Shares Out | 17 | 17 | 26 | 16 |
| Weighted Avg Shares Out Dil | 23 | 17 | 26 | 23 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $0 | $5 | $9 |
| % Margin | 14.6% | 0.4% | 7.3% | 8.3% |